The clinical significance of PD-L1 in advanced gastric cancer is dependent on ARID1A mutations and ATM expression.
Buglioni S, Melucci E, Sperati F, Pallocca M, Terrenato I, De Nicola F, Goeman F, Casini B, Amoreo CA, Gallo E, Diodoro MG, Pescarmona E, Vici P, Sergi D, Pizzuti L, Di Lauro L, Mazzotta M, Barba M, Fanciulli M, Vitale I, De Maria R, Ciliberto G, Maugeri-Saccà M.
Buglioni S, et al. Among authors: gallo e.
Oncoimmunology. 2018 Apr 24;7(8):e1457602. doi: 10.1080/2162402X.2018.1457602. eCollection 2018.
Oncoimmunology. 2018.
PMID: 30221053
Free PMC article.